Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
America must win the AI race — and prepare for the worst

Related Posts

Gold Price Update: Q2 2025 in Review

July 15, 2025

AUE achieves in excess of 95% gold recoveries...

December 28, 2024

Clinical trial data shows RAD 101 detects Brain...

February 10, 2025

Andrew O’Donnell: Gold, Silver, Energy Transition — Where...

January 21, 2025

Empire Metals

September 3, 2025

Tech 5: US Lifts EDA Restrictions for China,...

July 6, 2025

Manindi Ti-V-Fe Discovery Delivers High-Grade Concentrates

May 16, 2025

E-Power Resources Inc. Announces Closing of Oversubscribed Hard...

June 21, 2025

Harvest Gold Kicks Off Drilling at Mosseau, Launches...

August 15, 2025

John Hathaway: Gold Price Can Double, This Factor...

August 28, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Karine Jean-Pierre arrives for House Oversight grilling in Biden autopen probe
  • Top conservative speakers vow they ‘will not be silenced’ after Charlie Kirk’s assassination
  • Engravings on shooter’s ammo exposes Charlie Kirk assassination motive

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    September 13, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    September 13, 2025
  • Karine Jean-Pierre arrives for House Oversight grilling in Biden autopen probe

    September 13, 2025
  • Top conservative speakers vow they ‘will not be silenced’ after Charlie Kirk’s assassination

    September 13, 2025
  • Engravings on shooter’s ammo exposes Charlie Kirk assassination motive

    September 13, 2025
  • ‘This is on all of us’: Lawmakers take hard look at how political rhetoric played role in Kirk’s assassination

    September 13, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 3

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 4

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 5

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
Promotion Image

banner

Categories

  • Business (541)
  • Investing (1,968)
  • Politics (2,403)
  • Stocks (778)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved